EdgarLookup
SC 13G/A

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Company
CytomX Therapeutics, Inc.
Filed
February 11, 2021
Accession Number
0000921895-21-000340
View Document ↗ View on SEC.gov ↗